Colgate Palmolive logo

Colgate Palmolive

COLPAL NSE

Key Fundamentals

MidcapPersonal CareConsumer Goods
Market Cap
₹48,128 Cr
Volatility
Moderate
P/E Ratio
35.02
EBITDA
₹1,959 Cr
Return on Equity
83.66%
Debt to Equity
0.03
Book Value
₹58.24
EPS
₹51.99
52W High
₹2,329.9
52W Low
₹1,763.3

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

4
  • Company has reduced debt.
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 79.4%
  • Company has been maintaining a healthy dividend payout of 112%

Weaknesses

2
  • Stock is trading at 29.8 times its book value
  • The company has delivered a poor sales growth of 4.51% over past five years.

Growth Rate

Revenue Growth
-0.89% lower than 3Y
Net Income Growth
-7.76% lower than 3Y
Cash Flow Change
29.53% lower than 3Y
ROE
-3.08% lower than 3Y
ROCE
-3.34% lower than 3Y
EBITDA Margin (Avg.)
-5.77% higher than 3Y

AI Analysis — Bull vs Bear

6d ago
AI opinion · based on fundamentals
Risk medium

Colgate-Palmolive (India) has a market capitalisation of about ₹50,260 Cr and trades at 37.5x earnings and 31.88x book value. Its ROE is very high (83% last year, 79% over 3 years), it is almost debt-free, and its dividend yield is 2.59%. Sales have grown only about 5% a year over 3, 5 and 10 years, TTM profit fell 2%, and the stock has returned -17% over 1 year and -3% CAGR over 3 years.

Bull Case 7
  • Return on equity is very high and consistent: 83% last year, 79% over 3 years, 75% over 5 years and 66% over 10 years. This points to strong pricing power and a capital-light business.
  • The company is almost debt-free and has reduced debt further, so its balance sheet carries little financial risk. Data on its ₹50,260 Cr market cap shows no meaningful leverage.
  • The dividend yield of 2.59% is high for an Indian consumer staples company, and the dividend payout ratio is 112%, which gives shareholders a large cash return.
  • Profit has grown faster than sales over the long run: 10-year profit CAGR is 8% against 5% for sales, and 3-year profit CAGR is 8% against 5% for sales. This suggests margins have expanded over time.
  • The stock has fallen 17% over the past year while TTM profit fell only 2%. This means the valuation has de-rated, and the P/E now stands at 37.5.
  • Over 10 years the stock has compounded at 7% a year. Add the 2.59% dividend yield and the total return is roughly high single digits, with lower volatility than typical of defensive staples.
  • The 10-year average ROE of 66% has risen to 83% in the last year, so capital efficiency has improved even as growth slowed.
Bear Case 7
  • The stock trades at 31.88x book value, among the most expensive price-to-book multiples in the market. That leaves little room for error if earnings disappoint.
  • Sales growth is slow: 5-year sales CAGR is 4.51%, and the 3-year, 10-year and TTM figures are all 4–5%. This points to mature, saturated core categories.
  • Earnings momentum has turned negative. TTM profit growth is -2%, below the 3-year profit CAGR of 8%.
  • A P/E of 37.5 against sales growth of about 4–5% and TTM profit growth of -2% gives a high price relative to growth. The multiple depends on the company's defensive quality rather than on growth.
  • Shareholder returns have been weak: the stock returned -17% over 1 year, -3% CAGR over 3 years and just 2% CAGR over 5 years, lagging broader Indian equity indices.
  • A dividend payout of 112% means the company is paying out more than it earns. That cannot continue indefinitely without drawing down reserves, and it leaves little for reinvestment.
  • Much of the very high ROE (83%) comes from a small equity base, which is also why P/B is 31.88. So the ROE partly reflects a thin book value created by distributing more than 100% of profit, not only operating strength.

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

1d ago
Positives 1
  • KBC 18 oral health campaign Sep 10

    Colgate-Palmolive (India) has partnered with Kaun Banega Crorepati Season 18 on an oral health awareness campaign that encourages Indian families to brush at night. The tie-up gives the brand mass-market reach and could help increase usage frequency in the category.

Neutral 2
  • Abhijit Yadav named EVP-Legal Sep 28

    Abhijit Yadav will become Executive Vice President - Legal on October 24, 2026. He succeeds Priyan Pillay, who resigned to pursue opportunities abroad. This is a routine change in a senior role outside the core business.

  • J.P. Morgan investor meet Sep 17

    The company will join an in-person group meeting at the J.P. Morgan India Consumption Forum on September 23, 2026, at 9:00 am IST. It is a routine investor engagement, though management comments on demand trends could shape sentiment.

TL;DR: Recent news for Colgate-Palmolive (India) is light and mostly routine, with no clear headwinds in this set. The KBC 18 tie-up is a modest positive for brand visibility and category building. The legal head change and the investor meeting are not expected to move fundamentals much. With no earnings, pricing or volume data in these articles, the trend is stable, and the next real signals will be management's demand commentary and upcoming quarterly results.

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
1,324
1,471
1,396
1,490
1,497
1,619
1,462
1,463
1,434
1,520
1,486
1,595
1,603
Expenses
906
989
927
958
988
1,122
1,007
964
981
1,054
1,044
1,086
1,120
Operating Profit
418
482
468
532
508
497
454
498
453
465
442
510
483
OPM %
32%
33%
34%
36%
34%
31%
31%
34%
32%
31%
30%
32%
30%
Other Income
-5
21
18
23
23
76
20
19
18
15
31
0
19
Interest
1
1
2
1
1
1
1
1
1
1
1
1
1
Depreciation
44
44
41
42
42
42
41
38
38
37
36
35
39
PBT
369
458
443
511
489
530
433
478
432
442
436
474
462
Tax %
26%
26%
26%
26%
26%
26%
25%
26%
26%
26%
26%
25%
26%
Net Profit
274
340
330
380
364
395
323
355
321
328
324
353
343
EPS in Rs
10.06
12.5
12.14
13.96
13.38
14.52
11.87
13.05
11.79
12.04
11.91
12.99
12.61
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
3,982
3,868
3,982
4,188
4,462
4,525
4,841
5,100
5,226
5,680
6,040
6,035
6,204
Expenses
3,159
2,929
3,038
3,074
3,226
3,323
3,331
3,534
3,679
3,779
4,082
4,165
4,304
Operating Profit
823
940
944
1,114
1,236
1,202
1,510
1,566
1,547
1,901
1,958
1,870
1,900
OPM %
21%
24%
24%
27%
28%
27%
31%
31%
30%
33%
32%
31%
31%
Other Income
32
7
41
26
68
49
30
26
42
57
139
64
66
Interest
0
0
0
0
2
10
7
6
5
5
4
4
4
Depreciation
75
111
133
157
159
198
182
177
175
172
163
146
148
PBT
780
835
851
983
1,143
1,043
1,350
1,409
1,410
1,781
1,930
1,784
1,814
Tax %
28%
30%
32%
32%
32%
22%
23%
23%
26%
26%
26%
26%
—
Net Profit
559
581
577
673
776
816
1,035
1,078
1,047
1,324
1,437
1,325
1,348
EPS in Rs
20.55
21.37
21.23
24.76
28.52
30.02
38.07
39.65
38.5
48.67
52.83
48.73
49.55
Div. Payout %
58%
47%
47%
97%
81%
93%
100%
101%
101%
119%
97%
119%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
14
27
27
27
27
27
27
27
27
27
27
27
Reserves
757
1,004
1,247
1,497
1,420
1,567
1,139
1,707
1,689
1,847
1,637
1,557
Borrowings
0
0
0
0
83
102
91
83
69
72
61
47
Other Liabilities
932
972
1,037
1,039
1,097
908
1,637
1,084
1,098
1,250
1,293
1,777
Total Liabilities
1,702
2,003
2,311
2,564
2,626
2,604
2,894
2,902
2,883
3,197
3,019
3,408
Fixed Assets
782
1,008
1,108
1,146
1,191
1,123
1,065
963
862
794
776
718
CWIP
141
78
167
159
199
190
145
122
114
110
38
27
Investments
37
31
31
31
31
19
19
0
0
0
0
0
Other Assets
742
885
1,005
1,228
1,206
1,272
1,666
1,817
1,907
2,292
2,204
2,663
Total Assets
1,702
2,003
2,311
2,564
2,626
2,604
2,894
2,902
2,883
3,197
3,019
3,408
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
638
689
688
694
983
930
784
1,626
1,176
1,199
1,394
1,806
Investing
-272
-237
-342
-207
-96
-19
71
-108
-8
79
56
374
Financing
-385
-391
-341
-380
-815
-891
-956
-1,091
-1,087
-1,195
-1,671
-1,422
Net Cash Flow
-18
61
5
107
73
20
-101
427
82
83
-221
758
Free Cash Flow
339
417
367
485
879
869
727
1,576
1,107
1,123
1,323
1,730
CFO/OP
103
100
105
93
113
104
76
127
101
88
100
121
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
6
10
12
18
17
11
9
16
11
11
14
13
Inventory Days
63
72
72
56
58
69
79
78
68
63
76
75
Days Payable
128
136
148
152
144
142
179
169
155
187
185
275
Cash Conversion Cycle
-59
-55
-63
-79
-68
-63
-91
-75
-76
-113
-95
-188
Working Capital Days
-40
-43
-39
-33
-36
-23
-84
-25
-32
-46
-37
-59
ROCE %
114%
96%
74%
71%
73%
65%
92%
92%
79%
97%
105%
108%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Colgate Palmolive insights

70 extracted metrics + investor summaries across FY02–FY27.

Log in — free

Shareholding Pattern

Others2.57%Govt.0.28%Promot.51.00%FIIs13.59%DIIs15.54%Public17.01%As ofJun 2026

Documents

Frequently Asked Questions about Colgate Palmolive

What does Colgate-Palmolive (India) Ltd do?
Colgate-Palmolive India Ltd is engaged in manufacturing/ trading of toothpaste, tooth powder, toothbrush, mouthwash and personal care products.[1]
Where is Colgate-Palmolive (India) Ltd (COLPAL) listed?
Colgate-Palmolive (India) Ltd trades as COLPAL on the NSE and under code 500830 on the BSE.
Which sector does Colgate-Palmolive (India) Ltd belong to?
Colgate-Palmolive (India) Ltd is classified under the Consumer Goods sector, in the Personal Care industry.
What is the market capitalisation of Colgate-Palmolive (India) Ltd?
Colgate-Palmolive (India) Ltd has a market capitalisation of ₹48,128 Cr, which places it in the Large Cap band.
What is the PE ratio of Colgate-Palmolive (India) Ltd?
Colgate-Palmolive (India) Ltd trades at a PE ratio of 35.02, on earnings per share of ₹51.99, against a book value of ₹58.24 per share.
What is the 52-week high and low of Colgate-Palmolive (India) Ltd?
Over the last 52 weeks Colgate-Palmolive (India) Ltd has traded between ₹1,763.3 and ₹2,329.9.
Does Colgate-Palmolive (India) Ltd pay dividends?
Colgate-Palmolive (India) Ltd has a dividend yield of 2.72%.
What is the Return on Equity (ROE) of Colgate-Palmolive (India) Ltd?
Colgate-Palmolive (India) Ltd reported a return on equity of 83.66%. Its debt-to-equity ratio is 0.03.

Company Information

Colgate-Palmolive India Ltd is engaged in manufacturing/ trading of toothpaste, tooth powder, toothbrush, mouthwash and personal care products.[1]

Website colgate.co.in
CEO Ms. Prabha Narasimhan
Employees 2,198
Listed 2007-12-17
Face Value ₹ 1
Issued Size 27,19,85,634

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/COLPAL.md for Colgate-Palmolive (India) Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Consumer Goods → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List